Literature DB >> 11573845

Prescription drug use, diagnoses, and healthcare utilization among the elderly.

T Jörgensen1, S Johansson, A Kennerfalk, M A Wallander, K Svärdsudd.   

Abstract

BACKGROUND: More elderly patients affected by severe and chronic diseases are treated in primary care. Reports on the use of prescription drugs by the general elderly population are scarce, and more investigations are needed to optimize pharmaceutical care for these patients.
OBJECTIVE: To analyze prescription drug use, diagnoses, and healthcare utilization among noninstitutionalized elderly patients.
DESIGN: Retrospective cohort study. SETTING AND PATIENTS: All people > or =65 years old (n = 4642) living in the community of Tierp, Sweden, in 1994 were included. Prescription drug use and healthcare utilization have been registered for all inhabitants of the community since 1972. Information about filled prescriptions and diagnoses were obtained from a computerized research register.
RESULTS: Prescription drug use was high among the elderly (78%); the most used pharmacologic groups were cardiovascular, nervous system, and gastrointestinal medications. Women used more prescription drugs than men (average 4.8 vs. 3.8) and had more nonfatal diagnoses. Use of five or more different prescription drugs during 1994 was common (39.0%), and multivariate analysis showed that the greatest number of primary care visits occurred with multiple drug use (> or =5 drugs over 1 y).
CONCLUSIONS: This study shows an extensive multiple drug use among elderly people living at home. Whether this multiple drug use per se is harmful to the patients or not could not be evaluated in this study. Further focused investigations are needed to assess the effect of multiple drug use in an elderly population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573845     DOI: 10.1345/aph.10351

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  76 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

2.  Factors associated with potentially inappropriate medication use in community-dwelling older adults in the United States: a systematic review.

Authors:  Stephanie K Nothelle; Ritu Sharma; Allison Oakes; Madeline Jackson; Jodi B Segal
Journal:  Int J Pharm Pract       Date:  2019-04-09

3.  Prevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries.

Authors:  Xue Feng; Xi Tan; Brittany Riley; Tianyu Zheng; Thomas K Bias; James B Becker; Usha Sambamoorthi
Journal:  Ann Pharmacother       Date:  2017-06-21       Impact factor: 3.154

4.  Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study.

Authors:  Ding-Cheng Derrick Chan; Yi-Ting Hao; Shwu-Chong Wu
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Use of nonsteroidal anti-inflammatory drugs and coxibs in the elderly. Are we following the guidelines?

Authors:  Sergio Duran-Barragan; Anthony S Russell
Journal:  Clin Rheumatol       Date:  2008-07-12       Impact factor: 2.980

6.  Polypharmacy in Assisted Living and Impact on Clinical Outcomes.

Authors:  Barbara Resnick; Elizabeth Galik; Marie Boltz; Sarah Holmes; Steven Fix; Erin Vigne; Shijun Zhu; Regina Lewis
Journal:  Consult Pharm       Date:  2018-06-01

7.  Aging and Adherence to the Mediterranean Diet: Relationship with Cardiometabolic Disorders and Polypharmacy.

Authors:  R Vicinanza; G Troisi; R Cangemi; M U De Martino; D Pastori; S Bernardini; F Crisciotti; F Di Violante; A Frizza; M Cacciafesta; P Pignatelli; V Marigliano
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

8.  Variation over time in the association between polypharmacy and mortality in the older population.

Authors:  Kathryn Richardson; Alexandrine Ananou; Louise Lafortune; Carol Brayne; Fiona E Matthews
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

9.  Excessive polypharmacy and survival in polypathological patients.

Authors:  Jesús Díez-Manglano; Mercedes Giménez-López; Vanesa Garcés-Horna; María Sevil-Puras; Elena Castellar-Otín; Paloma González-García; Isabel Fiteni-Mera; Teresa Morlanes-Navarro
Journal:  Eur J Clin Pharmacol       Date:  2015-04-26       Impact factor: 2.953

10.  Drug use in a geriatric long-term care setting: comparison between newly admitted and institutionalised patients.

Authors:  Zeev Arinzon; Alexander Peisakh; Aneta Zuta; Yitshal N Berner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.